Table 1
Patient characteristics
| CLD | RDS | |
|---|---|---|
| *Curosurf®, Chiesi Pharmaceuticals, Parma, Italy. | ||
| †Significant differences were noted between the two groups for birth weight and gestation (both p<0.001). | ||
| CLD, chronic lung disease; Fio2, inspired fractional oxygen; MAP, mean airway pressure; PIP, peak inspiratory pressure; RDS, respiratory distress syndrome. | ||
| Number | 13 | 19 |
| Gestation (weeks) | 26 (23 to 28) | 31 (25 to 39)† |
| Birth weight (g) | 750 (630 to 1070) | 1400 (720 to 4160)† |
| Antenatal dexamethasone | 12/13 (92%) | 10/19 (53%) |
| Surfactant* | 12/13 (92%) | 16/19 (84%) |
| PIP (mean first 24 hours) | 17 (14 to 36) | 16 (11 to 22) |
| MAP (mean first 24 hours) | 8 (4 to 18) | 7 (4 to 13) |
| Fio2 (mean first 24 hours) | 0.37 (0.24 to 1.00) | 0.32 (0.21 to 0.76) |
